TITLE

Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis

AUTHOR(S)
Chilton, D.; Edwards, S. G.; Pellegrino, P.; Miller, R. F.
PUB. DATE
October 2008
SOURCE
Thorax;Oct2008, Vol. 63 Issue 10, p935
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article on factors that influences the delay in antiretroviral therapy among patients infected with HIV coinfected with tuberculosis.
ACCESSION #
35024649

 

Related Articles

  • Letter to the Editor: Hypersensitivity Reactions in Patients Treated with Abacavir: Strategies To Avoid Such Reactions. Kapoor, Shailendra // AIDS Patient Care & STDs;Oct2008, Vol. 22 Issue 10, p769 

    A letter to the editor is presented in response to the article "Recent Availability of Two Novel, Fixed Formulations of Antiretroviral Nucleoside Analogues: A 12-Month Prospective, Open-Label Survey of Their Practical Use and Therapeutic Perspectives in Antiretroviral-Naive and Experienced...

  • Allocating Antiretrovirals in South Africa: Using Modeling to Determine Treatment Equity. Wilson, David P.; Blower, Sally M. // PLoS Medicine;Jun2005, Vol. 2 Issue 6, p0563 

    Presents a response by David P. Wilson and Sally M. Blower to a letter to the editor about their article "Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries" in the 2005 issue.

  • Authors' Reply. Capron, Alexander M.; Reis, Andreas // PLoS Medicine;Jun2005, Vol. 2 Issue 6, p0564 

    Presents a letter to the editor in response to the article "Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries," by David P. Wilson and Sally M. Blower in the 2005 issue.

  • The Cost Effectiveness of Antiretroviral Therapy for HIV Disease. Messori, Andrea; Trippoli, Sabrina; Vaiani, Monica // New England Journal of Medicine;7/5/2001, Vol. 345 Issue 1, p68 

    A letter to the editor is presented in response to an article on the cost-effectiveness of antiretroviral therapy for human immunodeficiency virus (HIV) diseases, published in the March 15, 2001 issue.

  • The Cost Effectiveness of Antiretroviral Therapy for HIV Disease. Laurence, Jeffrey // New England Journal of Medicine;7/5/2001, Vol. 345 Issue 1, p68 

    A letter to the editor is presented in response to an article on the cost-effectiveness of antiretroviral therapy for human immunodeficiency virus (HIV) diseases, published in the March 15, 2001 issue.

  • The Cost Effectiveness of Antiretroviral Therapy for HIV Disease. Freedberg, Kenneth A.; Losina, Elena; Goldie, Sue J. // New England Journal of Medicine;7/5/2001, Vol. 345 Issue 1, p68 

    A esponse by Kenneth A. Freedberg et al. to a letter to the editor about their article on the cost-effectiveness of antiretroviral therapy for human immunodeficiency virus (HIV) diseases, published in the March 15, 2001 issue is presented.

  • Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome. Thorne, Claire; Fiore, Simona; Rudin, Christoph // New England Journal of Medicine;1/30/2003, Vol. 348 Issue 5, p471 

    A letter to the editor is presented in response to the article "Antiretroviral Therapy During Pregnancy and the Risk of an Adverse Outcome" in the June 13, 2002 issue.

  • Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome. Tuomala, Ruth E.; Shapiro, David E.; Mofenson, Lynne M. // New England Journal of Medicine;1/30/2003, Vol. 348 Issue 5, p471 

    A response by Ruth E. Tuomala and colleagues to a letter to the editor about their article "Antiretroviral Therapy During Pregnancy and the Risk of an Adverse Outcome" in the June 13, 2002 issue is presented.

  • The AIDS Pandemic. Reynolds, Steven J.; Quinn, Thomas C.; Bollinger, Robert C. // New England Journal of Medicine;8/21/2003, Vol. 349 Issue 8, p814 

    A response by Steven J. Reynolds et al. to a letter to the editor about their article "Antiretroviral Therapy Where Resources Are Limited," in the May 1, 2003 issue is presented.

  • Clinical experience of raltegravir-containing regimens in HIV-infected patients during rifampicin-containing treatment of tuberculosis. Mena, Álvaro; Vázquez, Pilar; Castro, Ángeles; López, Soledad; Bello, Laura; Pedreira, José D. // Journal of Antimicrobial Chemotherapy (JAC);Apr2011, Vol. 66 Issue 4, p951 

    A letter to the editor is presented in response to the article "Clinical Experience of Raltegravir-containing Regimens in HIV-infected Patients During Rifampicin-containing Treatment of Tuberculosis."

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics